VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus

The mechanisms underlying chronic hydrocephalus remain poorly understood. It is known that cerebral blood flow decreases in this condition, potentially leading to hypoxia. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are known to respond to hypoxic conditions. However, their specific roles in chronic hydrocephalus are unclear. Prior research has shown that VEGF is secreted by the choroid plexus, a structure central to cerebrospinal fluid production. This gap motivated a focus on VEGF and VEGFR-2 levels in brain regions affected by hydrocephalus. No prior work had resolved the relationship between VEGFR-2 levels and cerebral blood flow in this context. The choroid plexus's role in modulating CSF and growth factor levels remains underexplored in chronic hydrocephalus. This uncertainty drove the need to investigate how VEGF and VEGFR-2 levels change in key brain regions. Understanding these changes may help clarify the pathophysiology of chronic hydrocephalus.

The aim of this study was to examine changes in VEGF and VEGFR-2 levels in the frontal cortex and choroid plexus of a chronic hydrocephalus model. The specific problem addressed was the lack of understanding about how VEGF/VEGFR-2 signaling is affected by chronic hydrocephalus. The motivation stemmed from the known role of VEGF in hypoxia and its secretion by the choroid plexus. This condition is associated with altered CSF dynamics and reduced cerebral blood flow. The study sought to determine whether VEGFR-2 levels in the frontal cortex correlate with changes in blood flow. It also aimed to assess how CSF-VEGF levels change in ventricles after CSF outlet blockage. The researchers proposed that a hypoxic response might be reflected in these changes. This could provide insights into the pathophysiology of chronic hydrocephalus.

The study used an animal model of chronic hydrocephalus induced by blocking the CSF outlet. Cerebral blood flow was measured using laser Doppler flowmetry in the frontal cortex. VEGF and VEGFR-2 levels were quantified using immunohistochemistry and biochemical assays in the frontal cortex and choroid plexus. CSF samples were collected from ventricles to measure VEGF levels. The choroid plexus was analyzed for VEGF and VEGFR-2 expression. Correlations between cerebral blood flow and VEGFR-2 levels were assessed statistically. The model was compared with a sham-operated control group. The results were analyzed to determine whether observed changes were significant and meaningful.

Significant decreases in cerebral blood flow and VEGFR-2 levels were observed in the frontal cortex of the chronic hydrocephalus group compared to controls. VEGF levels in the frontal cortex did not show significant changes. Cerebral blood flow in the frontal cortex was positively correlated with VEGFR-2 levels (P=0.024). Immunohistochemistry revealed strong VEGF and VEGFR-2 expression in the choroid plexus. Ventricular CSF volume increased significantly after chronic hydrocephalus induction. CSF-VEGF levels in the ventricles also increased significantly. These findings suggest a possible hypoxic response in the frontal cortex. The increase in CSF-VEGF levels may reflect secretion from the choroid plexus following CSF outlet blockage.

The observed decrease in VEGFR-2 levels in the frontal cortex may be linked to reduced cerebral blood flow. The increase in CSF-VEGF levels in ventricles may indicate a hypoxic response or accumulation from choroid plexus secretion. These findings suggest that VEGF/VEGFR-2 signaling is modulated in chronic hydrocephalus. The choroid plexus appears to play a role in secreting VEGF into the CSF. The positive correlation between cerebral blood flow and VEGFR-2 levels supports a potential link between hypoxia and receptor downregulation. The study does not assign essentiality to any specific mechanism but proposes these as possible explanations. Further investigation into CSF-VEGF levels in different brain regions is suggested. This could improve understanding of VEGF/VEGFR-2 modulation in hydrocephalus and potentially inform therapeutic approaches.